{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T14:37:35Z","timestamp":1775918255848,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T00:00:00Z","timestamp":1540944000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007557","name":"California Institute of Regenerative Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007557","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone Reports"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.bonr.2018.10.003","type":"journal-article","created":{"date-parts":[[2018,11,3]],"date-time":"2018-11-03T12:20:55Z","timestamp":1541247655000},"page":"181-187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Prevalence of glucocorticoid induced osteonecrosis in the mouse is not affected by treatments that maintain bone vascularity"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0177-2198","authenticated-orcid":false,"given":"Nancy E.","family":"Lane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geetha","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1198-1161","authenticated-orcid":false,"given":"Wei","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kie","family":"Shidara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-An Evan","family":"Lay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Junjing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alanna","family":"Dubrovsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald B.","family":"Kimmel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bonr.2018.10.003_bb0005","first-page":"511","article-title":"Operative technique and results of core decompression and filling with bone grafts in the treatment of osteonecrosis of femoral head","volume":"12","author":"Bednarek","year":"2010","journal-title":"Ortop. Traumatol. Rehabil."},{"key":"10.1016\/j.bonr.2018.10.003_bb0010","first-page":"384","article-title":"Polymorphisms of the glucocorticoid receptor and avascular necrosis of the femoral heads after treatment with corticosteroids","volume":"2","author":"Bouamar","year":"2009","journal-title":"NDT Plus"},{"key":"10.1016\/j.bonr.2018.10.003_bb0015","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for assessment of bone microstructure in rodents using micro-computed tomography","volume":"25","author":"Bouxsein","year":"2010","journal-title":"J. Bone Min. Res."},{"key":"10.1016\/j.bonr.2018.10.003_bb0020","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.2106\/00004623-198668090-00002","article-title":"Core decompression of the femoral head for osteonecrosis","volume":"68","author":"Camp","year":"1986","journal-title":"J. Bone Joint Surg. Am."},{"key":"10.1016\/j.bonr.2018.10.003_bb0025","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1007\/s11999-017-5374-x","article-title":"Free vascularized fibular grafting improves vascularity compared with core decompression in femoral head osteonecrosis: a randomized clinical trial","volume":"475","author":"Cao","year":"2017","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.bonr.2018.10.003_bb0030","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2174\/1874325001206010449","article-title":"Glucocorticoid-induced avascular bone necrosis: diagnosis and management","volume":"6","author":"Chan","year":"2012","journal-title":"Open Orthop. J."},{"key":"10.1016\/j.bonr.2018.10.003_bb0035","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1002\/art.33498","article-title":"Alendronate in the prevention of collapse of the femoral head in nontraumatic osteonecrosis: a two-year multicenter, prospective, randomized, double-blind, placebo-controlled study","volume":"64","author":"Chen","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bonr.2018.10.003_bb0040","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1002\/term.2056","article-title":"Two-year follow-up after advanced core decompression","volume":"11","author":"Classen","year":"2017","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"10.1016\/j.bonr.2018.10.003_bb0045","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.2106\/00004623-199707000-00012","article-title":"Steroid-induced adipogenesis in a pluripotential cell line from bone marrow","volume":"79","author":"Cui","year":"1997","journal-title":"J. Bone Joint Surg. Am."},{"key":"10.1016\/j.bonr.2018.10.003_bb0050","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jbmr.1805","article-title":"Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee","volume":"28","author":"Dempster","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bonr.2018.10.003_bb0055","doi-asserted-by":"crossref","first-page":"e631","DOI":"10.3928\/01477447-20140626-54","article-title":"Osteonecrosis following short-term, low-dose oral corticosteroids: a population-based study of 24 million patients","volume":"37","author":"Dilisio","year":"2014","journal-title":"Orthopedics"},{"key":"10.1016\/j.bonr.2018.10.003_bb0060","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12891-015-0589-z","article-title":"Systemic application of teriparatide for steroid induced osteonecrosis in a rat model","volume":"16","author":"Dong","year":"2015","journal-title":"BMC Musculoskelet. Disord."},{"key":"10.1016\/j.bonr.2018.10.003_bb0065","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1517\/13543784.10.7.1309","article-title":"Anticoagulant therapy for osteonecrosis associated with heritable hypofibrinolysis and thrombophilia","volume":"10","author":"Glueck","year":"2001","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.bonr.2018.10.003_bb0070","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/nm.2665","article-title":"Directing mesenchymal stem cells to bone to augment bone formation and increase bone mass","volume":"18","author":"Guan","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.bonr.2018.10.003_bb0075","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/rheumatology\/keq044","article-title":"Gender difference in the development of steroid-induced osteonecrosis in rabbits","volume":"49","author":"Ikemura","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.bonr.2018.10.003_bb0080","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ajpath.2013.03.004","article-title":"Primary epiphyseal arteriopathy in a mouse model of steroid-induced osteonecrosis","volume":"183","author":"Janke","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bonr.2018.10.003_bb0085","first-page":"466","article-title":"Substrain-specific differences in survival and osteonecrosis incidence in a mouse model","volume":"62","author":"Kawedia","year":"2012","journal-title":"Comp. Med."},{"key":"10.1016\/j.bonr.2018.10.003_bb0090","first-page":"2155","article-title":"The use of alendronate to prevent early collapse of the femoral head in patients with nontraumatic osteonecrosis. A randomized clinical study","volume":"87","author":"Lai","year":"2005","journal-title":"J. Bone Joint Surg. Am."},{"key":"10.1016\/j.bonr.2018.10.003_bb0095","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1749-6632.2009.05228.x","article-title":"Glucocorticoid-induced bone fragility","volume":"1192","author":"Lane","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bonr.2018.10.003_bb0100","article-title":"Asparaginase potentiates glucocorticoid-induced osteonecrosis in a mouse model","volume":"11","author":"Liu","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bonr.2018.10.003_bb0105","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00223-016-0195-6","article-title":"A novel hybrid compound LLP2A-Ale both prevented and rescued the osteoporotic phenotype in a mouse model of glucocorticoid-induced osteoporosis","volume":"100","author":"Mohan","year":"2017","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bonr.2018.10.003_bb0110","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bonr.2018.10.003_bb0115","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nchembio798","article-title":"Combinatorial chemistry identifies high-affinity peptidomimetics against \u03b14\u03b21 integrin for in vivo tumor imaging","volume":"2","author":"Peng","year":"2006","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bonr.2018.10.003_bb0120","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/jbm.b.31770","article-title":"Micro-CT-based bone ceramic scaffolding and its performance after seeding with mesenchymal stem cells for repair of load-bearing bone defect in canine femoral head","volume":"96","author":"Peng","year":"2011","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"10.1016\/j.bonr.2018.10.003_bb0125","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.autrev.2010.06.007","article-title":"Steroid induced osteonecrosis: an analysis of steroid dosing risk","volume":"9","author":"Powell","year":"2010","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.bonr.2018.10.003_bb0130","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12016-010-8217-z","article-title":"Current concepts on the pathogenesis and natural history of steroid-induced osteonecrosis","volume":"41","author":"Powell","year":"2011","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.bonr.2018.10.003_bb0135","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1056\/NEJMoa071408","article-title":"Teriparatide or alendronate in glucocorticoid-induced osteoporosis","volume":"357","author":"Saag","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bonr.2018.10.003_bb0140","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1002\/art.24879","article-title":"Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: thirty-six-month results of a randomized, double-blind, controlled trial","volume":"60","author":"Saag","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bonr.2018.10.003_bb0145","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/jor.20765","article-title":"Functional perfusion MRI predicts later occurrence of steroid-associated osteonecrosis: an experimental study in rabbits","volume":"27","author":"Sheng","year":"2009","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.bonr.2018.10.003_bb0150","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2106\/00004623-198567010-00015","article-title":"The effect of core decompression on femoral head blood flow in steroid-induced avascular necrosis of the femoral head","volume":"67","author":"Wang","year":"1985","journal-title":"J. Bone Joint Surg. Am."},{"key":"10.1016\/j.bonr.2018.10.003_bb0155","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.bone.2009.06.030","article-title":"Glucocorticoids, osteocytes, and skeletal fragility: the role of bone vascularity","volume":"46","author":"Weinstein","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.bonr.2018.10.003_bb0160","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.ecl.2012.04.004","article-title":"Glucocorticoid-induced osteoporosis and osteonecrosis","volume":"41","author":"Weinstein","year":"2012","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"10.1016\/j.bonr.2018.10.003_bb0165","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s12020-011-9580-0","article-title":"Glucocorticoid-induced osteonecrosis","volume":"41","author":"Weinstein","year":"2012","journal-title":"Endocrine"},{"key":"10.1016\/j.bonr.2018.10.003_bb0170","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1172\/JCI2799","article-title":"Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone","volume":"102","author":"Weinstein","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bonr.2018.10.003_bb0175","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1210\/en.2009-1488","article-title":"Intermittent parathyroid hormone administration counteracts the adverse effects of glucocorticoids on osteoblast and osteocyte viability, bone formation, and strength in mice","volume":"151","author":"Weinstein","year":"2010","journal-title":"Endocrinology"},{"issue":"11","key":"10.1016\/j.bonr.2018.10.003_bb0180","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1210\/en.2017-00662","article-title":"The pathophysiological sequence of glucocorticoid-induced osteonecrosis of the femoral head in male mice","volume":"158","author":"Weinstein","year":"2017","journal-title":"Endocrinology"},{"key":"10.1016\/j.bonr.2018.10.003_bb0185","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1002\/art.34525","article-title":"Promotion of bone repair by implantation of cryopreserved bone marrow-derived mononuclear cells in a rabbit model of steroid-associated osteonecrosis","volume":"64","author":"Xie","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bonr.2018.10.003_bb0190","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/rheumatology\/ker197","article-title":"Effects of an anti-platelet drug on the prevention of steroid-induced osteonecrosis in rabbits","volume":"51","author":"Yamaguchi","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.bonr.2018.10.003_bb0195","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/jor.20733","article-title":"A mouse model for glucocorticoid-induced osteonecrosis: effect of a steroid holiday","volume":"27","author":"Yang","year":"2009","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.bonr.2018.10.003_bb0200","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.bone.2014.07.026","article-title":"Targeted delivery of mesenchymal stem cells to the bone","volume":"70","author":"Yao","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.bonr.2018.10.003_bb0205","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1002\/art.23454","article-title":"Glucocorticoid excess in mice results in early activation of osteoclastogenesis and adipogenesis and prolongd suppression of osteogenesis: a longitudinal study of gene expression in bone tissue from glucocorticoid-treated mice","volume":"58","author":"Yao","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bonr.2018.10.003_bb0210","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1002\/art.23954","article-title":"Glucocorticoid-induced bone loss in mice can be reversed by the actions of parathyroid hormone and risedronate on different pathways for bone formation and mineralization","volume":"58","author":"Yao","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bonr.2018.10.003_bb0215","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1002\/stem.1461","article-title":"Reversing bone loss by directing mesenchymal stem cells to bone","volume":"31","author":"Yao","year":"2013","journal-title":"Stem Cells"},{"key":"10.1016\/j.bonr.2018.10.003_bb0220","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1002\/stem.2433","article-title":"Improved mobilization of exogenous mesenchymal stem cells to bone for fracture healing and sex difference","volume":"34","author":"Yao","year":"2016","journal-title":"Stem Cells"},{"key":"10.1016\/j.bonr.2018.10.003_bb0225","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00198-015-3308-6","article-title":"Sclerostin-antibody treatment of glucocorticoid-induced osteoporosis maintained bone mass and strength","volume":"27","author":"Yao","year":"2016","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bonr.2018.10.003_bb0230","doi-asserted-by":"crossref","first-page":"455","DOI":"10.5435\/JAAOS-22-07-455","article-title":"Osteonecrosis of the femoral head: evaluation and treatment","volume":"22","author":"Zalavras","year":"2014","journal-title":"J. Am. Acad. Orthop. Surg."},{"key":"10.1016\/j.bonr.2018.10.003_bb0235","doi-asserted-by":"crossref","DOI":"10.1002\/sctm.17-0039","article-title":"Acceleration of fracture healing by overexpression of basic fibroblast growth factor in the mesenchymal stromal cells","author":"Zhang","year":"2017","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.bonr.2018.10.003_bb0240","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.bone.2011.11.002","article-title":"Treatment of early stage osteonecrosis of the femoral head with autologous implantation of bone marrow-derived and cultured mesenchymal stem cells","volume":"50","author":"Zhao","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.bonr.2018.10.003_bb0245","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00590-012-1054-4","article-title":"Osteonecrosis of the femoral head in SARS patients: seven years later","volume":"23","author":"Zhao","year":"2013","journal-title":"Eur. J. Orthop. Surg. Traumatol."},{"key":"10.1016\/j.bonr.2018.10.003_bb0250","article-title":"PTH[1-34] improves the effects of core decompression in early-stage steroid-associated osteonecrosis model by enhancing bone repair and revascularization","volume":"12","author":"Zhou","year":"2017","journal-title":"PLoS ONE"}],"container-title":["Bone Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352187218300548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352187218300548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T16:17:25Z","timestamp":1762445845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352187218300548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":50,"alternative-id":["S2352187218300548"],"URL":"https:\/\/doi.org\/10.1016\/j.bonr.2018.10.003","relation":{},"ISSN":["2352-1872"],"issn-type":[{"value":"2352-1872","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of glucocorticoid induced osteonecrosis in the mouse is not affected by treatments that maintain bone vascularity","name":"articletitle","label":"Article Title"},{"value":"Bone Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bonr.2018.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}